The Chinese government has announced that responsibilities relating to product recalls will be retained by the health ministry and the State Food and Drug Administration (SFDA), US industry association, AdvaMed, reports. The announcement, which came out of a meeting of the US-China ...
Clinica
China streamlines regulatory process
02 November 2009
Peter Rixon
Not a subscriber ? Request a FREE Trial
Subscribe to Clinica
RELATED CONTENT
NEWS
Clinica News
- New bills in US House, Senate aim to streamline FDA device reviews
- Ten notified bodies set to sign up to code of conduct as text explained
- EU IVD Directive: huge majority wants greater NB involvement
- Australian Senate committee voices shock at DePuy hip patient experiences, calls for stricter regulation
Other Informa News
Features & Analysis
Other Informa Analysis
EVENTS
19 March 2012
Montreux Convention and Music Centre, Switzerland
